SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZOLI, Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.410
AS - Asia 3.106
EU - Europa 1.409
SA - Sud America 583
AF - Africa 99
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.662
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.267
SG - Singapore 1.044
CN - Cina 832
IT - Italia 521
BR - Brasile 462
VN - Vietnam 332
HK - Hong Kong 282
DE - Germania 189
TR - Turchia 180
UA - Ucraina 140
GB - Regno Unito 120
BD - Bangladesh 97
FR - Francia 89
RU - Federazione Russa 82
IN - India 72
MX - Messico 63
CA - Canada 61
ID - Indonesia 55
AU - Australia 51
FI - Finlandia 51
PL - Polonia 50
AR - Argentina 43
NL - Olanda 40
ZA - Sudafrica 40
JP - Giappone 39
IQ - Iraq 25
SE - Svezia 25
ES - Italia 21
EC - Ecuador 20
IR - Iran 19
PH - Filippine 17
MA - Marocco 15
CO - Colombia 14
PK - Pakistan 14
MY - Malesia 12
UZ - Uzbekistan 12
VE - Venezuela 12
AT - Austria 11
CL - Cile 11
CZ - Repubblica Ceca 11
LT - Lituania 11
NG - Nigeria 11
PY - Paraguay 11
SA - Arabia Saudita 10
IE - Irlanda 9
TW - Taiwan 9
EG - Egitto 7
JO - Giordania 7
GR - Grecia 6
TN - Tunisia 6
CH - Svizzera 5
HU - Ungheria 5
KE - Kenya 5
KZ - Kazakistan 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
BE - Belgio 4
CR - Costa Rica 4
DZ - Algeria 4
HN - Honduras 4
KG - Kirghizistan 4
LB - Libano 4
NI - Nicaragua 4
PE - Perù 4
RS - Serbia 4
AF - Afghanistan, Repubblica islamica di 3
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
KR - Corea 3
NP - Nepal 3
PS - Palestinian Territory 3
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
DK - Danimarca 2
ET - Etiopia 2
GE - Georgia 2
JM - Giamaica 2
KH - Cambogia 2
LY - Libia 2
NZ - Nuova Zelanda 2
QA - Qatar 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
UY - Uruguay 2
BG - Bulgaria 1
BJ - Benin 1
BW - Botswana 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 9.656
Salva come PNG Salva come JPEG
Città #
Ashburn 737
Singapore 676
Fairfield 479
Santa Clara 344
San Jose 279
Hong Kong 277
Beijing 258
Woodbridge 211
Seattle 199
Wilmington 168
Cambridge 158
Izmir 157
Houston 156
Ho Chi Minh City 133
New York 90
Nanjing 78
Princeton 69
Hanoi 68
Lauterbourg 68
Dallas 67
Ann Arbor 63
Los Angeles 59
Jacksonville 56
Munich 54
São Paulo 52
Council Bluffs 51
Milan 51
Mexico City 43
Boardman 41
Warsaw 40
Bologna 39
Rome 37
Jakarta 34
Helsinki 33
London 32
Shanghai 32
Tokyo 32
San Diego 27
Sydney 27
Shenyang 26
Ferrara 25
Chandler 23
Chicago 23
Bremen 20
Florence 20
Atlanta 19
Brooklyn 18
Nanchang 18
Tianjin 18
Hebei 17
Jinan 17
Montreal 17
Orem 16
Guangzhou 15
Johannesburg 15
Turku 15
Buffalo 14
Frankfurt am Main 14
Rio de Janeiro 14
Toronto 14
Turin 14
Belo Horizonte 13
Changsha 13
Chennai 13
Haiphong 13
Imola 13
Jiaxing 13
Melbourne 13
Baghdad 12
Da Nang 12
Denver 12
Norwalk 12
Stockholm 11
Istanbul 10
Modena 10
Moscow 10
Nuremberg 10
Palermo 10
Bari 9
Falls Church 9
Mumbai 9
Ottawa 9
Porto Alegre 9
San Francisco 9
Brasília 8
Brno 8
Bắc Ninh 8
Dhaka 8
Fortaleza 8
Manchester 8
Mountain View 8
Phoenix 8
Quito 8
Reggio Nell'emilia 8
Taizhou 8
Verona 8
Zhengzhou 8
Amsterdam 7
Augusta 7
Calgary 7
Totale 6.246
Salva come PNG Salva come JPEG
Nome #
Effects of Ethanol on the Digestive System: A Narrative Review 385
Sindrome di Budd-Chiari a decorso fatale in paziente con policitemia vera e sindrome da anticorpi antifosfolipidi [Sindrome di Budd-Chiari a decorso fatale in paziente con policitemia vera e sindrome da anticorpi antifosfolipidi] 287
Alcohol Hub: il trattamento farmacologico dei disordini da uso di alcol 265
Sindrome da astinenza protratta da alcol: il ruolo del sodio ossibato...e non solo 214
Splenic autotransplantation after splenectomy: Tuftsin activity correlates with residual splenic function 200
A brief up-date of the use of sodium oxybate for the treatment of alcohol use disorder 194
Randomised controlled trial of mesalazine in IBS 193
Alcohol use disorder in the COVID-19 era: Position paper of the Italian Society on Alcohol (SIA) 190
Osteoporosis in Celiac Disease: An Update 185
Cardiac involvement in Crohn's disease: Echocardiographic study 179
Nutritional Treatment in Crohn’s Disease 172
Beyond biologics: advanced therapies in inflammatory bowel diseases 166
Alcohol use disorders in the elderly: A brief overview from epidemiology to treatment options 166
Effect of gluten-free diet on gut microbiota composition in patients with celiac disease and non-celiac gluten/wheat sensitivity 163
A controlled study of 20 mg famotidine nocte vs. 150 mg ranitidine nocte for the prevention of duodenal ulcer relapse 162
Alcohol use in patients with chronic liver disease 160
Alcohol use disorder and GABAB receptor gene polymorphisms in an Italian sample: haplotype frequencies, linkage disequilibrium and association studies 158
The course of inflammatory bowel disease during pregnancy and postpartum: A prospective European ECCO-EpiCom Study of 209 pregnant women 149
Alcohol use disorders and liver fibrosis: an update 147
An evaluation of factors affecting helicobacter pylori prevalence in tibetans exiled in india 147
A reassessment of splenic hypofunction in celiac disease 146
Adalimumab for a co-existing clinical condition of Crohn's disease and acrodermatitis continua of Hallopeau 146
Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA) 142
Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity 138
Impaired splenic function and tuftsin deficiency in patients with intestinal failure on long term intravenous nutrition 138
Life-threatening onset of coeliac disease: A case report and literature review 137
Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology (SIGE) 135
Sodium oxybate plus nalmefene for the treatment of alcohol use disorder: A case series 134
Evidence-based decision for pharmacological management of alcoholic liver disease and alcohol dependence 132
Prevalence of celiac disease in inflammatory bowel diseases: An IG-IBD multicentre study 128
Recurrent myocarditis in a patient with active ulcerative colitis: A case report and review of the literature 126
Gastrointestinal involvement in anderson-fabry disease: A narrative review 125
Impact of Female Gender in Inflammatory Bowel Diseases: A Narrative Review 124
CLINICAL APPLICATIONS OF SCANNING ELECTRON MICROSCOPY IN GASTROINTESTINAL DISEASES 123
Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: A review 123
Osteoporosis and Celiac Disease: Updates and Hidden Pitfalls 122
Plasma Norepinephrine, Weak Neurotransmitters, and Renin Activity During Active Tilting in Liver Cirrhosis: Relationship with Cardiovascular Homeostasis and Renal Function 122
Treatment of alcohol-use disorders 121
Mortality risk in a cohort of Italian alcoholic individuals treated for alcohol dependence 121
A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease 118
Sodium oxybate in maintaining alcohol abstinence in alcoholic patients according to Lesch typologies: A pilot study 117
Treatment of narcolepsy with cataplexy 116
Promotion of gallbladder emptying by intravenous aminoacids 116
Therapeutic options for coeliac disease: What else beyond gluten-free diet? 115
Subclinical coeliac disease: an anthropometric assessment 114
Cytophilic antibodies cause leucocyte migration inhibition in coeliac disease 113
Changes in peripheral blood lymphocytes and immune complexes in splenectomized patients: lack of correlation with residual splenic function 112
Efficacy and safety of capsule endoscopy in octogenarian patients: a retrospective study 111
Defective phagocyte activity in adult coeliac disease 109
Increased resting lipid oxidation in Crohn's disease 108
Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: An open comparative study 104
Impaired tuftsin activity in cirrhosis: Relationship with splenic function and clinical outcome 103
Gamma hydroxybutyric acid (GHB): A valid pharmacological opportunity for the treatment of alcohol dependence 102
Alcohol Use in Adults Reply 97
Increased energy expenditure in growing adolescents with Crohn's disease 93
Symptoms of protracted alcohol withdrawal in patients with alcohol use disorder: a comprehensive systematic review 91
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis 91
Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn's disease: Partial benefit by infiximab - A pilot study 90
Echocardiographic evaluation of anti-Tumor Necrosis Factor-α therapy with infliximab in patients without cardiac pathologies 90
Use of pyridoxine-alpha-ketoglutarate (PAK) in hepatic encephalopathy 88
Major gastrointestinal hemorrhage during anticoagulant therapy in patients with atrial fibrillation: When should treatment be resumed? [Emorragia gastrointestinale maggiore in corso di terapia anticoagulante nei pazienti con fibrillazione atriale: quando riprendere il trattamento? ] 87
Effect of arginine thiazolidinecarboxylate (ATCA)* * SULFILE is the trade name for arginine thiazolidinecarboxylate (200 mg vials) manufactured by Poli-Industria Chimica, Italy. on some clinical and functional parameters in cirrhotic patients 85
Identification of harmful drinking in subjects who have had their driving license suspended due to alcohol use: a retrospective Italian study 84
Tuftsin deficiency in AIDS 80
Il trattamento farmacologico della dipendenza da alcol 80
Ocular naevus and hyperaemia with dilation of the conjunctival vessels: An early manifestation of Crohn's disease? 77
Increased risk of breast cancer in first-degree relatives of Crohn's disease patients. An IG-IBD study 76
Efficacy and safety of gamma-hydroxybutyrate in treating alcohol withdrawal syndrome in an alcohol-dependent inpatient with decompensated liver cirrhosis: A case report 75
S.E.M. study I: Gastric and duodenal lesions induced by non-steroidal anti-inflammatory drugs (aspirin, piroxicam) in man 74
Ultrastructural aspects of duodenal mucosa repair during treatment of peptic disease 73
Failure of adrenergic system in the control of arterial pressure in cirrhosis. Role of weak neurotransmitters 71
S.E.M. study II. Protective effect of ranitidine against gastric and duodenal lesions induced by non-steroidal anti-inflammatory drugs 71
Howell‐Jolly body counting as a measure of splenic function. A reassessment 70
Pseudothrombocytopenia clinical comment on 37 cases 69
Famotidine vs ranitidine h.s. in acute duodenal ulcer. A multicentre endoscopic trial 69
The recognition and management of protracted alcohol withdrawal may improve and modulate the pharmacological treatment of alcohol use disorder 64
Famotidine and ranitidine in the prevention of duodenal ulcer 62
Totale 9.830
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.916
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.427
Totale 57.343
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 0 0 0 0 0 29
2021/2022404 22 33 4 24 10 30 24 34 16 73 18 116
2022/2023267 73 9 20 4 26 15 18 15 36 1 34 16
2023/2024387 10 19 10 18 26 15 6 15 10 17 44 197
2024/20251.774 57 92 170 97 210 207 37 68 185 321 172 158
2025/20264.697 372 223 464 663 702 266 466 318 392 499 233 99
Totale 9.830